Skip to main content
Premium Trial:

Request an Annual Quote

Primera Biosystems Closes $11M Stock Placement

NEW YORK, July 15 (GenomeWeb News) - Primera Biosystems announced this week that it has closed an $11 million placement of stock to a group of investors including MPM Capital, Burrill and Company, and the Malaysian Technology Development Corporation.

 

The company said the financing will enable it to develop both instrument systems and disease-specific diagnostic reagent kits for commercialization.

 

Primera is developing a gene expression analysis system called STAR (Scalable Transcription Analysis Routine) that combines features of real-time PCR and DNA microarray technologies.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.